Medical history included hypergonadotropic hypogonadism, which had not been further investigated. He was treated for 20 years with testosterone IM once monthly, which he stopped a year before the ...

The intended therapeutic effect of gonadotropin-releasing-hormone (GnRH) agonists is hypogonadism, which is a leading cause of osteoporosis in men. Observations are consistent with this effect ...

Medscape Extend is a transformative platform designed to revolutionise how pharmaceutical advertisers communicate with verified healthcare professionals (HCPs). Utilising the advanced capabilities ...